Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.52 |
| ▸ | GSK3B | P49841 | 14/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | GSK3A | P49840 | 2/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4480790 | 0.87 | DYRK1A (0.57) | AAK1GSK3BKDRHDAC6DYRK1A | |
| SCHEMBL4477055 | 0.87 | GSK3B (0.65) | AAK1GSK3BKDRHDAC6GSK3A | |
| SCHEMBL4494390 | 0.86 | GSK3B (0.49) | AAK1GSK3BHDAC6DYRK1AGSK3A | |
| SCHEMBL4483739 | 0.86 | AAK1 (0.58) | AAK1GSK3BKDRHDAC6DYRK1A | |
| SCHEMBL4484485 | 0.85 | ADORA3 (0.49) | GSK3BHDAC6GSK3AMAPK1 | |
| SCHEMBL4502197 | 0.84 | AAK1 (0.64) | AAK1GSK3BHDAC6CYP1A2GSK3A | |
| SCHEMBL4495082 | 0.83 | HDAC6 (0.66) | AAK1GSK3BKDRHDAC6DYRK1A | |
| SCHEMBL4506246 | 0.83 | GSK3B (0.67) | GSK3BCYP1A2 | |
| SCHEMBL4497978 | 0.82 | GSK3B (0.57) | GSK3BCYP1A2 | |
| SCHEMBL4480196 | 0.82 | FGFR1 (0.65) | AAK1GSK3BHDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |